121 related articles for article (PubMed ID: 28929751)
21. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.
Ozdemir ES; Jang H; Gursoy A; Keskin O; Nussinov R
J Phys Chem B; 2018 Aug; 122(30):7503-7513. PubMed ID: 29961325
[TBL] [Abstract][Full Text] [Related]
22. Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling.
Yelland T; Garcia E; Parry C; Kowalczyk D; Wojnowska M; Gohlke A; Zalar M; Cameron K; Goodwin G; Yu Q; Zhu PC; ElMaghloob Y; Pugliese A; Archibald L; Jamieson A; Chen YX; McArthur D; Bower J; Ismail S
J Med Chem; 2022 Feb; 65(3):1898-1914. PubMed ID: 35104933
[TBL] [Abstract][Full Text] [Related]
23. Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.
Ostrem JM; Shokat KM
Nat Rev Drug Discov; 2016 Nov; 15(11):771-785. PubMed ID: 27469033
[TBL] [Abstract][Full Text] [Related]
24. Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation.
Winter JJ; Anderson M; Blades K; Brassington C; Breeze AL; Chresta C; Embrey K; Fairley G; Faulder P; Finlay MR; Kettle JG; Nowak T; Overman R; Patel SJ; Perkins P; Spadola L; Tart J; Tucker JA; Wrigley G
J Med Chem; 2015 Mar; 58(5):2265-74. PubMed ID: 25695162
[TBL] [Abstract][Full Text] [Related]
25. 2-Phenylquinazolin-4(3H)-one, a class of potent PDE5 inhibitors with high selectivity versus PDE6.
Duan H; Zheng J; Lai Q; Liu Z; Tian G; Wang Z; Li J; Shen J
Bioorg Med Chem Lett; 2009 May; 19(10):2777-9. PubMed ID: 19375311
[TBL] [Abstract][Full Text] [Related]
26. DFT and molecular simulation validation of the binding activity of PDEδ inhibitors for repression of oncogenic k-Ras.
Majrashi TA; Sabt A; Almahli H; El Hassab MA; Noamaan MA; Elkaeed EB; Hamissa MF; Maslamani AN; Shaldam MA; Eldehna WM
PLoS One; 2024; 19(3):e0300035. PubMed ID: 38457483
[TBL] [Abstract][Full Text] [Related]
27. Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction.
Chen D; Chen Y; Lian F; Chen L; Li Y; Cao D; Wang X; Chen L; Li J; Meng T; Huang M; Geng M; Shen J; Zhang N; Xiong B
Eur J Med Chem; 2019 Feb; 163():597-609. PubMed ID: 30562696
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel PDEδ interacting proteins.
Küchler P; Zimmermann G; Winzker M; Janning P; Waldmann H; Ziegler S
Bioorg Med Chem; 2018 May; 26(8):1426-1434. PubMed ID: 28935183
[TBL] [Abstract][Full Text] [Related]
29. Fixing a hole where the Ras gets in.
Iwig JS; Kuriyan J
Cell; 2013 Jun; 153(6):1191-3. PubMed ID: 23746837
[TBL] [Abstract][Full Text] [Related]
30. Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.
Nishiguchi GA; Rico A; Tanner H; Aversa RJ; Taft BR; Subramanian S; Setti L; Burger MT; Wan L; Tamez V; Smith A; Lou Y; Barsanti PA; Appleton BA; Mamo M; Tandeske L; Dix I; Tellew JE; Huang S; Mathews Griner LA; Cooke VG; Van Abbema A; Merritt H; Ma S; Gampa K; Feng F; Yuan J; Wang Y; Haling JR; Vaziri S; Hekmat-Nejad M; Jansen JM; Polyakov V; Zang R; Sethuraman V; Amiri P; Singh M; Lees E; Shao W; Stuart DD; Dillon MP; Ramurthy S
J Med Chem; 2017 Jun; 60(12):4869-4881. PubMed ID: 28557458
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel KRAS‒PDE
Chen L; Zhang J; Wang X; Li Y; Zhou L; Lu X; Dong G; Sheng C
Acta Pharm Sin B; 2022 Jan; 12(1):274-290. PubMed ID: 35127385
[TBL] [Abstract][Full Text] [Related]
32. Substituted tetrahydroisoquinolines: synthesis, characterization, antitumor activity and other biological properties.
Capilla AS; Soucek R; Grau L; Romero M; Rubio-Martínez J; Caignard DH; Pujol MD
Eur J Med Chem; 2018 Feb; 145():51-63. PubMed ID: 29324343
[TBL] [Abstract][Full Text] [Related]
33. Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors.
Owen DR; Walker JK; Jon Jacobsen E; Freskos JN; Hughes RO; Brown DL; Bell AS; Brown DG; Phillips C; Mischke BV; Molyneaux JM; Fobian YM; Heasley SE; Moon JB; Stallings WC; Joseph Rogier D; Fox DN; Palmer MJ; Ringer T; Rodriquez-Lens M; Cubbage JW; Blevis-Bal RM; Benson AG; Acker BA; Maddux TM; Tollefson MB; Bond BR; Macinnes A; Yu Y
Bioorg Med Chem Lett; 2009 Aug; 19(15):4088-91. PubMed ID: 19540112
[TBL] [Abstract][Full Text] [Related]
34. Thermodynamic, dynamic and solvational properties of PDEδ binding to farnesylated cystein: a model study for uncovering the molecular mechanism of PDEδ interaction with prenylated proteins.
Suladze S; Ismail S; Winter R
J Phys Chem B; 2014 Jan; 118(4):966-75. PubMed ID: 24401043
[TBL] [Abstract][Full Text] [Related]
35. Identification of inhibitors of protein kinase B using fragment-based lead discovery.
Saxty G; Woodhead SJ; Berdini V; Davies TG; Verdonk ML; Wyatt PG; Boyle RG; Barford D; Downham R; Garrett MD; Carr RA
J Med Chem; 2007 May; 50(10):2293-6. PubMed ID: 17451234
[TBL] [Abstract][Full Text] [Related]
36. Membrane protein transport in photoreceptors: the function of PDEδ: the Proctor lecture.
Baehr W
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8653-66. PubMed ID: 25550383
[TBL] [Abstract][Full Text] [Related]
37. Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells.
Guo M; He S; Cheng J; Li Y; Dong G; Sheng C
ACS Med Chem Lett; 2022 Feb; 13(2):298-303. PubMed ID: 35178186
[TBL] [Abstract][Full Text] [Related]
38. Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C.
Zeng M; Lu J; Li L; Feru F; Quan C; Gero TW; Ficarro SB; Xiong Y; Ambrogio C; Paranal RM; Catalano M; Shao J; Wong KK; Marto JA; Fischer ES; Jänne PA; Scott DA; Westover KD; Gray NS
Cell Chem Biol; 2017 Aug; 24(8):1005-1016.e3. PubMed ID: 28781124
[TBL] [Abstract][Full Text] [Related]
39. An Internally Controlled Quantitative Target Occupancy Assay for Covalent Inhibitors.
Hansen R; Firdaus SJ; Li S; Janes MR; Zhang J; Liu Y; Zarrinkar PP
Sci Rep; 2018 Sep; 8(1):14312. PubMed ID: 30254226
[TBL] [Abstract][Full Text] [Related]
40. Assay and functional properties of PrBP(PDEdelta), a prenyl-binding protein interacting with multiple partners.
Zhang H; Hosier S; Terew JM; Zhang K; Cote RH; Baehr W
Methods Enzymol; 2005; 403():42-56. PubMed ID: 16473576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
